Wang Yd

Idarubicin-intensified haploidentical HSCT with GvHD prophylaxis of ATG and basiliximab provides comparable results to sibling donors in high-risk acute leukemia

X. Lu, R. Zhang, W. Shi, 2017, Bone Marrow Transplantation.